首页 > 市场调查报告书 > 材料

塑胶

市场调查报告书

商品编码

1634239

全球泡腾片市场 - 2024 - 2031

Global Effervescent Tablet Market - 2024 - 2031

出版日期: 2025年01月13日 | 出版商:

DataM Intelligence | 英文 159 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2023年，全球泡腾片市场规模达99.8亿美元，预估至2031年将达201.3亿美元，2024-2031年预测期间复合年增长率为9.17%。

泡腾片是透过压制由柠檬酸和碳酸氢钠组成的泡腾颗粒而製成的。当这些药片浸入水中时，酸和碱之间的反应产生二氧化碳，在液体中表现为气泡。这些片剂的快速崩解有助于快速溶解和吸收。

泡腾片的市占率受到多个变数的影响，这些变数增强了泡腾片在众多领域的吸引力和扩张，包括便利性、膳食补充剂需求增加、药品用途和不断增长的非处方药市场。过量服用某些泡腾片可能会导致有害影响而不是治疗效果，从而限制市场扩张。由于各种驱动力，该行业正在经历大幅扩张。

泡腾片在老年人中的普及率不断上升是一项重大发展，因为这些片剂为行动不便或吞嚥固体形式有困难的个人提供了方便和促进摄入。青少年和儿童泡腾补充剂的激增正在扩大市场范围，使其成为许多年龄层的多功能选择。与可能需要延长消化时间的传统药物相比，泡腾减肥补充剂可以更快发挥作用，从而促进体重控制工作更快取得成果。

动力学

驱动因素 1 - 对膳食补充剂的需求不断增长

随着消费者越来越追求简单、愉快和有效的方法来改善他们的健康和保健，对营养补充剂的需求不断增长，极大地推动了泡腾片市场的发展。泡腾片可快速吸收并促进消化，使其成为注重健康人士的首选。

对维生素、矿物质和草药补充剂的需求不断增长，尤其是千禧世代和健康爱好者，促使製造商开发和扩大其泡腾产品系列。此外，泡腾製剂的吸引力通常与增强风味和愉悦的消费体验有关，这与消费者对能够轻鬆融入生活方式的功能性产品的倾向相一致，从而推动了该领域的成长。

维生素C是公认的膳食维生素，具有增强免疫力的特性。维生素C泡腾片因其口感好、服用方便而受到消费者的欢迎。维生素 C 泡腾片比传统维生素 C 片或胶囊更受欢迎，因为它们能够溶解在水中，形成可口的泡腾饮料。多种维生素是公认的营养补充剂，含有多种维生素和矿物质。

多种维生素泡腾片提供全面的解决方案，以方便、愉快的方式满足日常营养需求。负责任营养委员会的膳食补充剂年度调查表明，美国膳食补充剂的使用量已达到历史最高水准。民调显示，76% 的美国人会使用膳食补充剂，比去年的 74% 增加。这些资料显示人们对膳食补充剂的兴趣和依赖日益增加，以增强整体健康和保健。这推动了泡腾片产业的扩张。

驱动因素 2 - 提高病患依从性和治疗效率

泡腾片提高患者依从性的能力是一个重要因素，尤其是难以吞嚥传统片剂的患者，包括老年人、儿童和吞嚥困难患者。这种新颖的配方将药物转化为美味且易于摄取的液体，满足了医疗保健领域未满足的重大需求。

泡腾技术除了简单的管理之外还具有多种优点。泡腾片透过添加大量活性药物成分 (API) 来提高溶解度和生物利用度，从而加快治疗效果并减少胃肠道刺激。由水环境中酸碱反应驱动的快速溶解过程说明了它们在给药方面的功效。这些特性使得泡腾片特别适用于疏水性或在某些 pH 条件下不稳定的活性药物成分，从而将其用途扩展到不同的治疗领域。

最近的创新增强了泡腾片的适应性。创新包括胃滞留和缓释製剂，促进有针对性的药物分布，延长在胃肠道的停留时间并最大限度地减少给药频率。这不仅改善了治疗效果，也减少了不良反应，从而提高了患者的依从性。

限制因素：生产成本高

由于对复杂生产技术和特定包装的要求，泡腾片的生产要求很高。这些药丸极易受潮，需要低湿度和密封包装的规范生产条件以确保稳定性。优质辅料和复杂配方的使用增加了生产成本。 FDA 和 EMA 等监管机构实施严格的品质标准，以确保泡腾产品的安全性和有效性，特别是在药品和膳食补充剂领域。

製造商必须遵守良好生产规范 (GMP) 并执行严格的测试来满足这些标准，从而提高营运成本。过高的费用可能会导致零售价格上涨，从而限制价格敏感市场的可及性。这种经济障碍限制了消费者的采用并阻碍了市场渗透，特别是在新兴领域，因此成为市场扩张的重大限制。

Effervescent tablets are manufactured by compressing effervescent granules composed of citric acid and sodium bicarbonate. When these tablets are immersed in water, the reaction between the acid and the base generates carbon dioxide, manifesting as gas bubbles in the liquid. The rapid disintegration of these tablets facilitates swift dissolving and absorption.

The market share of effervescent tablets is influenced by multiple variables that enhance their appeal and expansion across numerous sectors, including convenience, heightened demand for dietary supplements, pharmaceutical uses and the growing over-the-counter market. Excessive consumption of certain effervescent pills can lead to detrimental effects instead of therapeutic benefits, hence constraining market expansion. The industry is undergoing substantial expansion owing to various driving forces.

The rising prevalence of effervescent tablets among the elderly is a significant development, as these tablets provide convenience and facilitate intake for individuals with mobility challenges or difficulties in swallowing solid forms. The proliferation of effervescent supplements for youth and children is broadening the market's scope, rendering it a versatile option for many age demographics. In contrast to traditional drugs that may require extended digestion time, effervescent weight reduction supplements provide a more rapid commencement of action, hence promoting swifter outcomes in weight control endeavors.

Dynamics

Driver 1 - Growing Demand for Dietary Supplements

The rising demand for nutritional supplements is substantially propelling the effervescent tablet market as customers increasingly pursue easy, pleasant and efficacious methods to improve their health and wellness. Effervescent tablets provide rapid absorption and facilitate digestion, rendering them a favored option for health-conscious persons.

The increasing demand for vitamins, minerals and herbal supplements, especially among millennials and health aficionados, has prompted manufacturers to develop and broaden their effervescent product offerings. Moreover, the allure of effervescent formulations, frequently linked to enhanced flavor and pleasurable consumption experiences, corresponds with consumer inclinations for functional items that integrate effortlessly into their lifestyles, thereby propelling growth in this sector.

Vitamin C is a recognized dietary vitamin possessing immune-enhancing properties. Effervescent vitamin C tablets have gained popularity among customers due to their agreeable taste and convenient administration. Effervescent vitamin C tablets are favored over conventional vitamin C tablets or capsules due to their ability to dissolve in water, creating a palatable and effervescent beverage. Multivitamins are recognized nutritional supplements containing an assortment of vitamins and minerals.

Effervescent multivitamin tablets offer a comprehensive solution for fulfilling daily nutritional requirements in a convenient and enjoyable manner. The Council for Responsible Nutrition's Annual Survey on Dietary Supplements indicates that dietary supplement utilization in the US has reached a record peak. The poll indicates that 76% of individuals in the US will utilize dietary supplements, an increase from 74% the prior year. This data illustrates the increasing interest in and reliance on dietary supplements to enhance overall health and wellness. This propels the expansion of the effervescent tablet industry.

Driver 2 - Advancing Patient Compliance and Therapeutic Efficiency

The ability of effervescent tablets to enhance patient compliance, especially in patients who struggle to swallow traditional tablets, including the elderly, children and those with dysphagia, is a significant factor. This novel formulation converts medication into a tasty and easily ingestible fluid, fulfilling a significant unmet need in healthcare.

Effervescence technology has various advantages beyond simple administration. Effervescent tablets boost solubility and bioavailability by adding substantial quantities of Active Pharmaceutical Ingredients (APIs), resulting in expedited therapeutic effects with reduced gastrointestinal irritation. The fast dissolution process, driven by an acid-base reaction in an aqueous environment, illustrates their efficacy in drug administration. The characteristics render effervescent tablets especially appropriate for active pharmaceutical ingredients that are hydrophobic or unstable in certain pH conditions, thus expanding their utility across diverse therapeutic domains.

Recent innovations have enhanced the adaptability of effervescent pills. Innovations include gastro-retentive and slow-release formulations facilitate targeted medication distribution, extending residence duration in the gastrointestinal tract and minimizing dose frequency. This not only improves therapeutic results but also reduces adverse effects, hence increasing patient compliance.

Restraint: High Production Costs

The manufacturing of effervescent tablets is high due to the requirement for sophisticated production techniques and specific packaging. These pills are extremely susceptible to moisture, requiring regulated production conditions with low humidity and sealed packaging to ensure stability. The utilization of premium excipients and sophisticated formulations increases production expenses. Regulatory bodies like the FDA and EMA impose rigorous quality standards to guarantee the safety and efficacy of effervescent products, particularly in pharmaceutical and dietary supplement contexts.

Manufacturers must comply with Good Manufacturing Practices (GMP) and perform stringent testing to fulfill these standards, hence elevating operational costs. Exorbitant expenses can result in increased retail pricing, constraining accessibility in price-sensitive markets. This economic obstacle limits consumer adoption and impedes market penetration, especially in emerging areas, therefore serving as a substantial constraint on market expansion.

Segment Analysis

The global effervescent tablet market is segmented based on product type, form, packaging type, type, application, distribution channel and region.

Rising Enhanced Packaging

Aluminum and plastic tubes signify a notable improvement in packaging solutions for effervescent tablets, effectively mitigating essential issues related to moisture exposure that can negatively impact product quality. In the nutritional supplement sector, moisture can infiltrate packaging, resulting in early breakdown, color degradation, diminished efficacy or the emergence of unpleasant odors in effervescent pills.

In addition to moisture protection, the packaging design of aluminum and plastic tubes markedly improves brand visibility and consumer recognition at the point of sale. The potential for photorealistic printing enables firms to produce visually striking packaging that distinguishes itself in a saturated market.

Diverse surface textures, removable labels and cost-effective CMYK printing with a maximum of eight colors, inclusive of metallic finishes, empower businesses to convey vital product information in an appealing and clear manner. This focus on visual appeal, coupled with effective branding methods, corresponds with the growing consumer inclination towards health-oriented products, hence enhancing brand loyalty and consumer engagement.

The utilization of low-migration paints and varnishes that conform to international food safety standards highlights a dedication to safety and compliance in the packaging of effervescent tablets. By using for aluminium or plastic tubes for packaging, producers may safeguard their effervescent products from environmental influences while maintaining a professional and aesthetically pleasing presentation.

Geographical Penetration

Rising prevalence of chronic diseases in North America

The rising prevalence of chronic diseases and the presence of significant market players are ascribed to regional expansion. CDC statistics indicates that in 2020, there were 1,603,844 newly reported cancer cases in the US, along with 602,347 documented cancer-related deaths. For every 100,000 individuals, there were 403 newly diagnosed instances of cancer and 144 cancer-related fatalities. The FDA oversees dietary supplements and medications.

Dietary supplements, particularly effervescent tablets, are required to comply with FDA requirements. The FDA regulations safeguard product safety and quality, influencing market access and growth in North America. Moreover, the region's growing senior demographic and novel product launches propel market revenue.

Competitive Landscape

The major players in the market include Pfizer Inc., Novartis AG, Perrigo Company plc, Bristol-Myers Squibb Company, CHIESI SAS, Hermes Pharma, Herbalife International of America, Inc., Vovantis Laboratories, Natur Produkt Zdrovit Sp Z O O and Amerilab Technologies Inc.

Sustainability Analysis

The sustainability of the effervescent tablet market is supported by its environmentally friendly characteristics and its conformity with changing consumer and industry trends. Effervescent tablets, especially in cleaning applications, are biodegradable and eco-friendly, leaving no detrimental residues in ecosystems. Their compact, concentrated formulations diminish the necessity for unnecessary product application, therefore reducing waste and resource usage. This efficiency aligns with consumer aspirations for sustainable and economical cleaning solutions.

Innovations in packaging enhance the market's sustainability. Effervescent pills advantageously utilize the increasing transition towards bio-based and biodegradable packaging. Traditionally, the plastics sector depended significantly on fossil-derived materials; however, recent innovations have resulted in a greater utilization of renewable resources in packaging. Bio-based plastics, present in various forms since the 19th century, are seeing a resurgence, providing feasible solutions for mitigating the environmental impact of packaging.

Effervescent products also address the trend of minimizing packaging via e-commerce and subscription-based distribution models. These strategies correspond with consumer initiatives to reduce their ecological impact while maintaining convenience. The variety of effervescent tablets, which includes applications from denture cleaners to household cleaning agents, enhances their market appeal and emphasizes their contribution to sustainable consumption practices.

Consumer Behaviour Analysis

Consumer behavior regarding effervescent tablets indicates an increasing demand for alternative supplement delivery methods, as demonstrated by the surge in non-pill supplements, which currently represent approximately 34% of US supplement sales. The change is driven by consumers' inclination towards pleasurable and convenient alternatives, with formats like as candies, drink mixes and effervescent tablets becoming more favored than conventional pills. Gummy supplements have attained an impressive growth in recent years, underscoring the desire for formats that integrate functionality with an enjoyable experience.

Effervescent tablets provide a unique benefit by delivering nutrients in a palatable, carbonated beverage, attracting consumers who value flavor and convenience. These traits correspond with trends noted in other formats, where 52% of gummy consumers identify taste as the paramount characteristic, above affordability (37%) and high-quality components (25%). Effervescent pills address the demand for convenient, portable solutions that may be used without water, appealing to busy, health-conscious persons.

The increasing focus on clean-label supplements, propelled by Millennials and Gen Z, enhances the attractiveness of effervescent tablets. Consumers are progressively pursuing products containing natural ingredients, devoid of preservatives and artificial additives, hence affirming the appeal of effervescent tablets in the dynamic supplement industry.

Early Stage Innovations

Effervescent tablet formulations indicate an emerging invention with potential uses in sustained and gastro-retentive medication delivery systems. Recent developments underscore their promise in tackling critical obstacles including quick medication onset, restricted bioavailability and frequent dosage necessities. Effervescent tablets of nateglinide exhibited 99% drug release after 24 hours and maintained stability under diverse environmental conditions, addressing the limited duration of insulinotropic activity in the treatment of type II diabetes mellitus. The tablets, formulated using direct compression, employed excipients such as ethyl cellulose and Carbopol 930, with compatibility verified by FTIR and DSC analyses.

Effervescent floating tablets of fluoxetine for the treatment of depression demonstrated a 96% release within 12 hours, conforming to the Korsmeyer-Peppas release model. Their reliability is emphasized by stability under temperature and humidity fluctuations, as well as strong rheological qualities. Domperidone tablets exemplify a 98% release over 12 hours, underscoring their ability to improve medication absorption in particular gastrointestinal areas.

Effervescent formulations of silymarin flavonolignans for hepatic disorders demonstrated sustained release (95% over 16 hours), demonstrating zero-order kinetics and strong mechanical characteristics. These advances collectively highlight the potential of effervescent tablets to boost therapeutic results by improving drug delivery efficiency and patient compliance, indicating a disruptive approach in pharmaceutical research.

Emerging Market Players and Strategic Initiatives

Effervescent tablets are experiencing a renewed popularity because of changing customer preferences and innovations in manufacturing methods. Despite being generally regarded as an "old-fashioned" dosage type, their increasing market demand highlights its significance in contemporary healthcare. The global effervescent tablet market, valued at $356.3 million in 2023, is anticipated to expand at a strong CAGR of 6.8%, reaching $570.3 million by 2030. This expansion is propelled by their ease of consumption, better flavor and quick medicinal effects, which correspond with customer demands for convenience and an improved user experience.

New entrants are utilizing advanced manufacturing techniques, like TOPO granulation and unique horizontally aligned granulator technology, to enhance the stability, flavor and cost-effectiveness of effervescent tablets. These innovations facilitate accelerated production cycles, diminished carbon footprints and improved shelf life, especially in adverse climates.

Pharmaceutical companies are now strategically reintroducing effervescent tablets as luxury products, leveraging recent technology advancements. Companies are investigating novel formulations with distinctive active ingredients to address various customer categories, including the elderly and younger populations. In doing so, businesses are both broadening their product ranges and strengthening their market position in a competitive and dynamic environment.

Key Developments

In April 2022, Health Innovations Ltd., a UK-based maker of healthcare supplements, launched a novel EfferShield technology for effervescent pills and powders. This proprietary method has been designed to offer clients easy packaging solutions, including single-use pouches and stick packs.

Why Purchase the Report?

To visualize the global effervescent tablet market segmentation based on product type, form, packaging type, type, application, distribution channel and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the effervescent tablet market with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global effervescent tablet market report would provide approximately 86 tables, 88 figures and 202 pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Form
3.3. Snippet by Packaging Type
3.4. Snippet by Type
3.5. Snippet by Application
3.6. Snippet by Distribution Channel
3.7. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Demand for Dietary Supplements
  - 4.1.1.2. Advancing Patient Compliance and Therapeutic Efficiency
- 4.1.2. Restraints
  - 4.1.2.1. High Production Costs
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Nutritional Supplements*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Pharmaceuticals
6.4. Dietary Products
6.5. Energy Boosters
6.6. Others

7. By Form

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 7.1.2. Market Attractiveness Index, By Form
7.2. Enteric Coated Tablets*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Sublingual Tablets
7.4. Chewable Tablets
7.5. Others

8. By Packaging Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 8.1.2. Market Attractiveness Index, By Age Group
8.2. Plastic/Aluminium Tubes*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Sachets
8.4. Blister Packaging
8.5. Others

9. By Type

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.1.2. Market Attractiveness Index, By Type
9.2. Prescription*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Over the counter

10. By Application

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.1.2. Market Attractiveness Index, By Application
10.2. Personal Care and Beauty*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Food and Beverage
10.4. Sports and Fitness
10.5. Marine
10.6. Others

11. By Distribution Channel

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.1.2. Market Attractiveness Index, By Distribution Channel
11.2. Pharmaceuticals*
- 11.2.1. Introduction
- 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Supermarkets
11.4. eCommerce
11.5. Others

12. By Region

12.1. Introduction
- 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 12.1.2. Market Attractiveness Index, By Region
12.2. North America
- 12.2.1. Introduction
- 12.2.2. Key Region-Specific Dynamics
- 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 12.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.2.9.1. US
  - 12.2.9.2. Canada
  - 12.2.9.3. Mexico
12.3. Europe
- 12.3.1. Introduction
- 12.3.2. Key Region-Specific Dynamics
- 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 12.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.3.9.1. Germany
  - 12.3.9.2. UK
  - 12.3.9.3. France
  - 12.3.9.4. Italy
  - 12.3.9.5. Spain
  - 12.3.9.6. Rest of Europe
12.4. South America
- 12.4.1. Introduction
- 12.4.2. Key Region-Specific Dynamics
- 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 12.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.4.9.1. Brazil
  - 12.4.9.2. Argentina
  - 12.4.9.3. Rest of South America
12.5. Asia Pacific
- 12.5.1. Introduction
- 12.5.2. Key Region-Specific Dynamics
- 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 12.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.5.9.1. China
  - 12.5.9.2. India
  - 12.5.9.3. Japan
  - 12.5.9.4. Australia
  - 12.5.9.5. Rest of Asia Pacific
12.6. Middle East and Africa
- 12.6.1. Introduction
- 12.6.2. Key Region-Specific Dynamics
- 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

13. Competitive Landscape

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. Company Profiles

14.1. Pfizer Inc.*
- 14.1.1. Company Overview
- 14.1.2. Product Portfolio and Description
- 14.1.3. Financial Overview
- 14.1.4. Key Developments
14.2. Novartis AG
14.3. Perrigo Company plc
14.4. Bristol-Myers Squibb Company
14.5. CHIESI SAS
14.6. Hermes Pharma
14.7. Herbalife International of America, Inc.
14.8. Vovantis Laboratories
14.9. Natur Produkt Zdrovit Sp Z O O
14.10. Amerilab Technologies Inc.

LIST NOT EXHAUSTIVE